IBNSINA Statistics

Total Valuation

The IBN SINA Pharmaceutical Industry has a market cap or net worth of BDT 9.12 billion. The enterprise value is 10.65 billion.

Market Cap	9.12B
Enterprise Value	10.65B

Important Dates

The last earnings date was Monday, November 4, 2024.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	Oct 28, 2024

Share Statistics

The IBN SINA Pharmaceutical Industry has 31.24 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	31.24M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	44.31%
Float	n/a

Valuation Ratios

The trailing PE ratio is 13.60 and the forward PE ratio is 11.22.

PE Ratio	13.60
Forward PE	11.22
PS Ratio	0.80
PB Ratio	2.61
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.99, with an EV/FCF ratio of -60.98.

EV / Earnings	15.88
EV / Sales	0.94
EV / EBITDA	5.99
EV / EBIT	11.64
EV / FCF	-60.98

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.53.

Current Ratio	1.13
Quick Ratio	0.24
Debt / Equity	0.53
Debt / EBITDA	1.06
Debt / FCF	-10.80
Interest Coverage	17.07

Financial Efficiency

Return on equity (ROE) is 20.38% and return on invested capital (ROIC) is 12.08%.

Return on Equity (ROE)	20.38%
Return on Assets (ROA)	9.93%
Return on Capital (ROIC)	12.08%
Revenue Per Employee	2.71M
Profits Per Employee	159,648
Employee Count	4,000
Asset Turnover	1.98
Inventory Turnover	4.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.81%
50-Day Moving Average	327.37
200-Day Moving Average	278.96
Relative Strength Index (RSI)	38.33
Average Volume (20 Days)	242,203

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, The IBN SINA Pharmaceutical Industry had revenue of BDT 11.37 billion and earned 670.52 million in profits. Earnings per share was 21.46.

Revenue	11.37B
Gross Profit	4.53B
Operating Income	914.57M
Pretax Income	894.70M
Net Income	670.52M
EBITDA	1.75B
EBIT	914.57M
Earnings Per Share (EPS)	21.46

Full Income Statement

Balance Sheet

The company has 365.23 million in cash and 1.89 billion in debt, giving a net cash position of -1.50 billion or -47.86 per share.

Cash & Cash Equivalents	365.23M
Total Debt	1.89B
Net Cash	-1.50B
Net Cash Per Share	-47.86
Equity (Book Value)	3.53B
Book Value Per Share	111.94
Working Capital	302.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 438.88 million and capital expenditures -613.51 million, giving a free cash flow of -174.62 million.

Operating Cash Flow	438.88M
Capital Expenditures	-613.51M
Free Cash Flow	-174.62M
FCF Per Share	-5.59

Full Cash Flow Statement

Margins

Gross margin is 39.85%, with operating and profit margins of 8.04% and 5.90%.

Gross Margin	39.85%
Operating Margin	8.04%
Pretax Margin	7.87%
Profit Margin	5.90%
EBITDA Margin	15.41%
EBIT Margin	8.04%
FCF Margin	-1.54%

Dividends & Yields

This stock pays an annual dividend of 6.30, which amounts to a dividend yield of 2.16%.

Dividend Per Share	6.30
Dividend Yield	2.16%
Dividend Growth (YoY)	5.00%
Years of Dividend Growth	n/a
Payout Ratio	26.83%
Buyback Yield	n/a
Shareholder Yield	2.16%
Earnings Yield	7.35%
FCF Yield	-1.92%

Dividend Details

Stock Splits

The last stock split was on October 23, 2018. It was a forward split with a ratio of 1.1.

Last Split Date	Oct 23, 2018
Split Type	Forward
Split Ratio	1.1

Scores

The IBN SINA Pharmaceutical Industry has an Altman Z-Score of 4.68.

Altman Z-Score	4.68
Piotroski F-Score	n/a